physicians should be instructed regarding the possible manifestations of tcdd exposure to look for chloracne , soft tissue masses , muscle pain , fatigue , peripheral neuropathy , tender hepatic enlargement , enlargement , elevated liver enzymes , elevated lipids , prolonged prothrombin time , hemorrhagic cystitis and hirsutism .
C0019209
hepatic enlargement
C0020564
enlargement